The Therapeutic Effect of a Biodegradable Long-Acting Intravitreal Implant Containing CGK012 on Neovascular Age-Related Macular Degeneration by Promoting β-Catenin Degradation
Seoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang, Sangtaek Oh, Mary J Meegan · 2025
Read The Therapeutic Effect of a Biodegradable Long-Acting Intravitreal Implant Containing CGK012 on Neovascular Age-Related Macular Degeneration by Promoting β-Catenin Degradation by Seoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang, Sangtaek Oh, Mary J Meegan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12736000.txt.
Description
Seoyoung Park and co-authors report a 2025 study of a slow-release eye implant for a form of age-related sight loss. In this illness, new blood vessels grow under the retina and harm sight. Standard care needs shots in the eye again and again, and some patients respond poorly.
The implant holds a drug called CGK012, which breaks down a protein that drives vessel growth. In cell tests, the drug cut growth and swelling factors and slowed harmful cell change. In rabbits with the vessel growth trait, the loaded implant was tested for effect, release pace, and spread inside the eye.
Catalog record
| CREATOR | Seoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang, Sangtaek Oh, Mary J Meegan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |